600420 国药现代
已收盘 07-23 15:00:00
资讯
新帖
简况
长寿药NMN概念盘中拉升,翰宇药业涨5.48%
市场透视 · 07-22 02:04
长寿药NMN概念盘中拉升,翰宇药业涨5.48%
动物疫苗概念盘中跳水,温氏股份跌0.17%
市场透视 · 07-22 01:35
动物疫苗概念盘中跳水,温氏股份跌0.17%
每周股票复盘:XD国药现(600420)国药现代2025年半年报净利润6.721亿元同比减少6.46%
证券之星 · 07-19
每周股票复盘:XD国药现(600420)国药现代2025年半年报净利润6.721亿元同比减少6.46%
国药现代:上半年营收48.78亿元,部分青霉素类原料药及中间体销量走低
财经网 · 07-18
国药现代:上半年营收48.78亿元,部分青霉素类原料药及中间体销量走低
集采降价与需求疲软双重挤压!国药现代上半年营收净利双双下滑
读创 · 07-17
集采降价与需求疲软双重挤压!国药现代上半年营收净利双双下滑
国药现代(600420.SH)上半年归母净利润6.72亿元,同比下降6.46%
智通财经 · 07-17
国药现代(600420.SH)上半年归母净利润6.72亿元,同比下降6.46%
长寿药NMN概念盘中跳水,*ST亚太跌1.01%
市场透视 · 07-15
长寿药NMN概念盘中跳水,*ST亚太跌1.01%
每周股票复盘:国药现代(600420)每股派发现金红利0.20元
证券之星 · 07-12
每周股票复盘:国药现代(600420)每股派发现金红利0.20元
国药现代2024年度每股派发现金红利0.20元,7月18日发放
中访网数据 · 07-10
国药现代2024年度每股派发现金红利0.20元,7月18日发放
国药现代股价微跌0.18%,2024年度分红方案出炉
金融界 · 07-09
国药现代股价微跌0.18%,2024年度分红方案出炉
继“华润系”之后,“国药系”也要出售资产了!
制药网 · 07-07
继“华润系”之后,“国药系”也要出售资产了!
国药现代:公司将积极推进中长期发展战略规划
互动易 · 07-04
国药现代:公司将积极推进中长期发展战略规划
国药现代:2024年度现金分红总额将占净利润的37.13%
证券之星 · 07-04
国药现代:2024年度现金分红总额将占净利润的37.13%
化妆品概念盘中跳水,国药现代跌0.19%
市场透视 · 07-02
化妆品概念盘中跳水,国药现代跌0.19%
中国创新药能否持续让世界买单?券商分析师最新观点
券商中国 · 06-30
中国创新药能否持续让世界买单?券商分析师最新观点
国药现代:拟公开转让控股子公司51%股权
格隆汇 · 06-30
国药现代:拟公开转让控股子公司51%股权
国药现代:培哚普利吲达帕胺片获得药品注册证书
格隆汇 · 06-30
国药现代:培哚普利吲达帕胺片获得药品注册证书
动物疫苗概念盘中跳水,蔚蓝生物跌0.31%
市场透视 · 06-30
动物疫苗概念盘中跳水,蔚蓝生物跌0.31%
每周股票复盘:国药现代(600420)阿奇霉素干混悬剂通过一致性评价
证券之星 · 06-28
每周股票复盘:国药现代(600420)阿奇霉素干混悬剂通过一致性评价
上海现代制药修订独立董事制度 强化公司治理与中小股东权益保护
中访网数据 · 06-27
上海现代制药修订独立董事制度 强化公司治理与中小股东权益保护
加载更多
公司概况
公司名称:
上海现代制药股份有限公司
所属行业:
医药制造业
上市日期:
2004-06-16
主营业务:
上海现代制药股份有限公司的主营业务是医药产品研发、生产与销售。公司的主要产品是医药中间体、原料药、化学制剂、动物疫苗、大健康。公司位列2023年度“中国化药企业TOP100排行榜”第13名。
发行价格:
8.08
{"stockData":{"symbol":"600420","market":"SH","secType":"STK","nameCN":"国药现代","latestPrice":11.12,"timestamp":1753254000000,"preClose":11.17,"halted":0,"volume":14829741,"delay":0,"changeRate":-0.0045,"floatShares":1341000000,"shares":1341000000,"eps":0.8305,"marketStatus":"已收盘","change":-0.05,"latestTime":"07-23 15:00:00","open":11.11,"high":11.22,"low":11.08,"amount":166000000,"amplitude":0.0125,"askPrice":11.12,"askSize":318,"bidPrice":11.11,"bidSize":82,"shortable":0,"etf":0,"ttmEps":0.8305,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.17,"symbolType":"stock","openAndCloseTimeList":[[1753234200000,1753241400000],[1753246800000,1753254000000]],"highLimit":12.29,"lowLimit":10.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1341172692,"isCdr":false,"pbRate":1.1,"roa":"--","peRate":13.389524,"roe":"2.7%","epsLYR":0.808,"committee":-0.104729,"marketValue":14914000000,"turnoverRate":0.0111,"status":1,"floatMarketCap":14914000000},"requestUrl":"/m/hq/s/600420","defaultTab":"news","newsList":[{"id":"2553283656","title":"长寿药NMN概念盘中拉升,翰宇药业涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553283656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553283656?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:04","pubTimestamp":1753149856,"startTime":"0","endTime":"0","summary":"07月22日,长寿药NMN概念盘中拉升,截至10点04分,长寿药NMN概念整体指数上涨0.51%,报1154.640点。从个股上来看,该概念的成分股中,翰宇药业涨5.48%,德展健康、众生药业、国药现代涨幅居前。从资金上来看,截止发稿,长寿药NMN概念主力净流入为-2513.81万,其中翰宇药业受到资金热捧,主力净流入4978.92万;拉长时间线来看,该板块近20日主力资金净流入-44.54亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722100416954c1113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722100416954c1113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0010","BK0028","300199","BK0020","BK0082","BK0188","600420","BK0077","BK0132","BK0070"],"gpt_icon":0},{"id":"2553288140","title":"动物疫苗概念盘中跳水,温氏股份跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288140?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:35","pubTimestamp":1753148129,"startTime":"0","endTime":"0","summary":"07月22日,动物疫苗概念盘中跳水,截至09点35分,动物疫苗概念整体指数下跌0.52%,报990.020点。从个股上来看,该概念的成分股中,温氏股份跌0.17%,国药现代、瑞普生物跌幅居前。从资金上来看,截止发稿,动物疫苗概念主力净流入为-3267.58万,其中天邦食品受到资金热捧,主力净流入525.31万;拉长时间线来看,该板块近20日主力资金净流入-4.08亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093529a6b96966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722093529a6b96966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0194","BK0082","BK0012","BK0020","BK0187","BK0195","BK0010","600420","300498","BK0028","BK0239","BK0132","BK0196","BK0240","BK0188"],"gpt_icon":0},{"id":"2552417210","title":"每周股票复盘:XD国药现(600420)国药现代2025年半年报净利润6.721亿元同比减少6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417210","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417210?lang=zh_cn&edition=full","pubTime":"2025-07-20 05:09","pubTimestamp":1752959352,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘,XD国药现报收于10.93元,较上周的11.02元下跌0.82%。本周,XD国药现7月16日盘中最高价报11.24元。7月18日盘中最低价报10.79元。公司公告汇总2025年上半年,国药现代营业总收入4877673521.93元,同比下降18.16%;营业利润920163725.85元,同比下降16.10%;利润总额924926954.05元,同比下降14.86%;归属于上市公司股东的净利润672066877.31元,同比下降6.46%;基本每股收益0.5011元,同比下降6.46%;加权平均净资产收益率4.96%,下降0.68个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600420"],"gpt_icon":0},{"id":"2552451926","title":"国药现代:上半年营收48.78亿元,部分青霉素类原料药及中间体销量走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2552451926","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552451926?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:16","pubTimestamp":1752812170,"startTime":"0","endTime":"0","summary":"近日,国药现代发布2025年半年度业绩快报。披露上半年营收减少18.16%至48.78亿元,归属净利减少6.46%至6.72亿元。报告期内,受市场供需影响,公司部分青霉素类原料药及中间体的销量、价格同比走低;制剂业务板块,部分头孢类、激素类、神经类产品受药品集中采购及终端需求减少等因素影响,销售收入同比有所下降。面对市场竞争压力,公司聚焦战略布局,积极推进科研开发,加大市场深耕力度,持续推进提质增效、降本控费,期间费用下降明显,有效稳定了盈利空间。(企业公告)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121852a4528329&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121852a4528329&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600420"],"gpt_icon":0},{"id":"2552100643","title":"集采降价与需求疲软双重挤压!国药现代上半年营收净利双双下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2552100643","media":"读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552100643?lang=zh_cn&edition=full","pubTime":"2025-07-17 17:29","pubTimestamp":1752744551,"startTime":"0","endTime":"0","summary":"国药现代7月17日盘后发布2025年半年度业绩快报,公司实现营业收入48.78亿元,同比下降18.16%;归母净利润6.72亿元,同比下滑6.46%。国药现代业绩下滑主要受两大核心业务拖累。国药现代2025年一季报显示,公司实现营业收入为26.1亿元,同比下降16.5%;归母净利润为3.61亿元,同比上升9.1%;扣非归母净利润为3.46亿元,同比上升6.2%;经营现金流净额为3.05亿元,同比下降57.2%来源:读创财经","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717173138a450c008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717173138a450c008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600420"],"gpt_icon":0},{"id":"2552049071","title":"国药现代(600420.SH)上半年归母净利润6.72亿元,同比下降6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552049071","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552049071?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:28","pubTimestamp":1752740923,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药现代(600420.SH)披露2025年半年度业绩快报,公司上半年营业总收入48.78亿元,同比下降18.16%;归属于上市公司股东的净利润6.72亿元,同比下降6.46%;归属于上市公司股东的扣除非经常性损益的净利润6.37亿元,同比下降6.72%。基本每股收益0.5011元。报告期内,受市场供需影响,公司部分青霉素类原料药及中间体的销量、价格同比走低;制剂业务板块,部分头孢类、激素类、神经类产品受药品集中采购及终端需求减少等因素影响,销售收入同比有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600420"],"gpt_icon":0},{"id":"2551130543","title":"长寿药NMN概念盘中跳水,*ST亚太跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551130543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551130543?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:33","pubTimestamp":1752546807,"startTime":"0","endTime":"0","summary":"07月15日,长寿药NMN概念盘中跳水,截至10点33分,长寿药NMN概念整体指数下跌2.05%,报1109.510点。从个股上来看,该概念的成分股中,*ST亚太跌1.01%,国药现代、晨光生物、华润双鹤跌幅居前。从资金上来看,截止发稿,长寿药NMN概念主力净流入为-5.53亿,其中百合股份受到资金热捧,主力净流入788.53万;拉长时间线来看,该板块近20日主力资金净流入-42.17亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510332797a66e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510332797a66e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0102","BK0177","BK0229","600420","603102","BK0082","000691","BK0132","BK0139","BK0071","BK0020","BK0022","BK0239","BK0010"],"gpt_icon":0},{"id":"2551919735","title":"每周股票复盘:国药现代(600420)每股派发现金红利0.20元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919735","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919735?lang=zh_cn&edition=full","pubTime":"2025-07-13 04:28","pubTimestamp":1752352088,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,国药现代报收于11.02元,较上周的10.99元上涨0.27%。本周,国药现代7月7日盘中最高价报11.09元。7月8日盘中最低价报10.79元。国药现代当前最新总市值147.8亿元,在化学制药板块市值排名36/150,在两市A股市值排名1109/5149。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0132","600420","BK0020","BK0239","BK0082"],"gpt_icon":0},{"id":"2550388664","title":"国药现代2024年度每股派发现金红利0.20元,7月18日发放","url":"https://stock-news.laohu8.com/highlight/detail?id=2550388664","media":"中访网数据","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550388664?lang=zh_cn&edition=full","pubTime":"2025-07-10 08:04","pubTimestamp":1752105861,"startTime":"0","endTime":"0","summary":"中访网数据 上海现代制药股份有限公司今日发布2024年度权益分派实施公告,拟向全体股东每10股派发现金红利2.00元(含税),合计派发金额达2.68亿元。本次分红以公司总股本13.41亿股为基数,股权登记日为2025年7月17日,除权除息日及现金红利发放日均为7月18日。公司大股东中国医药集团等5家机构则由公司自行派发。此次利润分配方案已于2025年6月26日经公司年度股东大会审议通过,体现了国药现代持续回报股东的承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071008140297a03d41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071008140297a03d41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0132","BK0082","600420","BK0020","BK0010"],"gpt_icon":0},{"id":"2550831657","title":"国药现代股价微跌0.18%,2024年度分红方案出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2550831657","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550831657?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:23","pubTimestamp":1752081816,"startTime":"0","endTime":"0","summary":"截至2025年7月9日收盘,国药现代股价报10.86元,较前一交易日下跌0.02元,跌幅0.18%。当日成交量为89221手,成交金额达0.97亿元,总市值为145.65亿元。国药现代主营业务涵盖化学制药、生物疫苗等领域。公司作为医药制造企业,产品线覆盖原料药、制剂等多个领域。公司于7月9日晚间发布2024年度权益分派实施公告,拟向全体股东每10股派发现金红利2元(含税)。本次分红股权登记日为2025年7月17日,除权除息日及现金红利发放日均为7月18日。风险提示:股市有风险,投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710013107979fe89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710013107979fe89e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0239","BK0010","BK0132","600420","BK0020"],"gpt_icon":0},{"id":"2549309325","title":"继“华润系”之后,“国药系”也要出售资产了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2549309325","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549309325?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:08","pubTimestamp":1751857726,"startTime":"0","endTime":"0","summary":"资料显示,国药哈森目前在销品种规模较小,且与公司下属其他子公司产品重叠度较高。无独有偶,华润系在资产调整方面也动作频频。无论是 “国药系” 还是 “华润系”,近年来资产出售动作均明显增多,通过转让低效资产,实现 “瘦身健体、提质增效”。国药现代与华润系的案例为行业内其他企业提供了借鉴,未来,更多的医药企业或将加入资源整合的行列,通过合理的资产运作实现可持续发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070711092795390aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070711092795390aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0020","600420","BK0239","BK0132","BK0010"],"gpt_icon":0},{"id":"2548369172","title":"国药现代:公司将积极推进中长期发展战略规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2548369172","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548369172?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:15","pubTimestamp":1751616901,"startTime":"0","endTime":"0","summary":"有投资者向国药现代提问, 石药集团94年上市,市值13亿,到25年市值820亿。云南白药93年上市,市值3亿,到25年市值1000亿。恒瑞医药20年上市,市值38亿,到25年市值3500亿。药明康德07年上市,市值76亿,到25年市值1900亿。贵司04年上市,到25年融资108亿,但市值仅143亿。贵公司就不能并购一些创新医药资产或研发管线来提升公司自身研发创新实力吗?实在不行扬子江药业还没上市,可以考虑收购掉扬子江药业公司回答表示,尊敬的投资者:您好!感谢您的建议,公司将积极推进中长期发展战略规划,促进公司稳步健康发展,持续回报投资者。感谢您的长期关注和支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704162834a72e66b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704162834a72e66b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0132","BK0020","BK0239","BK0082","600420"],"gpt_icon":0},{"id":"2548500363","title":"国药现代:2024年度现金分红总额将占净利润的37.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548500363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548500363?lang=zh_cn&edition=full","pubTime":"2025-07-04 15:54","pubTimestamp":1751615656,"startTime":"0","endTime":"0","summary":"证券之星消息,国药现代07月04日在投资者关系平台上答复投资者关心的问题。投资者提问:公司目前现金储备比较充沛,24年分红比例过低,请问董秘或证代。综合考虑公司于2024年9月已实施的2024年中期分红情况,2024年度公司现金分红总额将占2024年度归属于上市公司股东净利润的37.13%。同时,公司2024年度股东大会已审议通过《关于2025年中期分红安排的议案》,投资者可以关注后续有关披露信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400022315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600420"],"gpt_icon":0},{"id":"2548385255","title":"化妆品概念盘中跳水,国药现代跌0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548385255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548385255?lang=zh_cn&edition=full","pubTime":"2025-07-02 13:52","pubTimestamp":1751435537,"startTime":"0","endTime":"0","summary":"07月02日,化妆品概念盘中跳水,截至13点52分,化妆品概念整体指数下跌1.03%,报1630.070点。从个股上来看,该概念的成分股中,国药现代跌0.19%,德展健康、方盛制药跌幅居前。从资金上来看,截止发稿,化妆品概念概念主力净流入为-4.09亿,其中宜安科技受到资金热捧,主力净流入5798.06万;拉长时间线来看,该板块近20日主力资金净流入-68.07亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507021352179796dbfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507021352179796dbfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0132","BK0020","BK0082","BK0239","600420"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单?券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计,2025年1—5月,中国创新药企对外授权交易总金额已达455亿美元,超过2024年上半年的交易总额,创新药出海授权交易大爆发。亮眼数据的背后,是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力,正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期,年内大涨明显的创新药企业荣昌生物股价近期大幅回调,从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600380","600222","600513","600557","603567","ONC","600535","603087","159992","600351","688177","600200","688317","603707","688505","600062","600422","600080","688117","600332","688235","600420","600721","603590","688136","BK0239","600521","688166","688488","603229","688222","603259","688091","688073","688278","688331","688321","601607","600056","600276","600682","688336","600196","688513","603998","688189","603127","688131","688181","06160","600881","688202","688356","688319","600774","600789","600867","603367","600079","600572","688520","605199","600216","688163","600998","601089","603716","688506","688198","600851","688068","603456","600645","600267"],"gpt_icon":0},{"id":"2547067972","title":"国药现代:拟公开转让控股子公司51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2547067972","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547067972?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:49","pubTimestamp":1751276980,"startTime":"0","endTime":"0","summary":"格隆汇6月30日|国药现代公告,为推进实施公司中长期战略规划,优化资源配置,提高公司资产的运营效率,公司拟转让控股子公司上海现代哈森(商丘)药业有限公司51%股权,并在上海联合产权交易所进行预挂牌。交易对手尚不明确,尚未签署交易合同,无履约安排。本次控股子公司股权公开转让事项尚需获得上级主管单位中国医药集团有限公司审批。国药哈森2025年1-4月营业收入1.01亿元,净利润-1989.8万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301750499794711b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301750499794711b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","BK0132","BK0020","BK0082","BK0239","600420"],"gpt_icon":0},{"id":"2547406797","title":"国药现代:培哚普利吲达帕胺片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2547406797","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547406797?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:49","pubTimestamp":1751276961,"startTime":"0","endTime":"0","summary":"格隆汇6月30日丨国药现代(600420.SH)公布,公司全资子公司国药集团工业有限公司(称国药工业)收到国家药品监督管理局核准签发的培哚普利吲达帕胺片《药品注册证书》。培哚普利吲达帕胺片是由培哚普利叔丁胺和吲达帕胺组成的复方片剂,用于治疗成人原发性高血压。本品适用于单独服用培哚普利不能完全控制血压的患者。本次国药工业的培哚普利吲达帕胺片获得药品注册证书并视同通过一致性评价,将进一步丰富公司心血管领域的制剂产品群,有利于进一步增强公司在相关用药领域的综合市场竞争力,为公司未来发展带来积极影响。上述事项对公司当前经营业绩不会产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063017492895311a6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063017492895311a6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0020","BK0132","600420","BK0010","BK0082","BK0239"],"gpt_icon":0},{"id":"2547031796","title":"动物疫苗概念盘中跳水,蔚蓝生物跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547031796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547031796?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:36","pubTimestamp":1751247400,"startTime":"0","endTime":"0","summary":"06月30日,动物疫苗概念盘中跳水,截至09点36分,动物疫苗概念整体指数下跌0.72%,报914.330点。从个股上来看,该概念的成分股中,蔚蓝生物跌0.31%,国药现代、温氏股份、大北农跌幅居前。从资金上来看,截止发稿,动物疫苗概念主力净流入为-1384.45万,其中大北农受到资金热捧,主力净流入170.65万;拉长时间线来看,该板块近20日主力资金净流入-9.82亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630093640a724de87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630093640a724de87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0226","159646","BK0132","603739","BK0082","600420","BK0020","BK0010"],"gpt_icon":0},{"id":"2547701281","title":"每周股票复盘:国药现代(600420)阿奇霉素干混悬剂通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2547701281","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547701281?lang=zh_cn&edition=full","pubTime":"2025-06-29 06:41","pubTimestamp":1751150472,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,国药现代报收于10.7元,较上周的10.46元上涨2.29%。本周,国药现代6月27日盘中最高价报10.75元。近日,上海现代制药股份有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,批准阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900001189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600420","BK0239","BK0132","BK0020","BK0010","BK0082"],"gpt_icon":0},{"id":"2546588768","title":"上海现代制药修订独立董事制度 强化公司治理与中小股东权益保护","url":"https://stock-news.laohu8.com/highlight/detail?id=2546588768","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546588768?lang=zh_cn&edition=full","pubTime":"2025-06-27 08:15","pubTimestamp":1750983336,"startTime":"0","endTime":"0","summary":"中访网数据 上海现代制药股份有限公司于2024年年度股东大会审议通过修订后的《独立董事制度》,进一步规范独立董事任职条件、职责权限及履职保障机制,以提升公司治理水平,保护中小股东权益。此外,上海现代制药将建立独立董事专门会议机制,审议关联交易、承诺变更等重大事项,并明确会议召集、表决及记录保存要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627082414952d4419&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627082414952d4419&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600420","BK0010","BK0239","BK0082","BK0132","BK0020"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753254741576,"stockEarnings":[{"period":"1week","weight":0.0155},{"period":"1month","weight":0.0874},{"period":"3month","weight":0.1108},{"period":"6month","weight":-0.0135},{"period":"1year","weight":-0.081},{"period":"ytd","weight":-0.0473}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海现代制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40821人(较上一季度增加7.60%)","perCapita":"32854股","listingDate":"2004-06-16","address":"上海市浦东新区建陆路378号","registeredCapital":"134117万元","survey":" 上海现代制药股份有限公司的主营业务是医药产品研发、生产与销售。公司的主要产品是医药中间体、原料药、化学制剂、动物疫苗、大健康。公司位列2023年度“中国化药企业TOP100排行榜”第13名。","listedPrice":8.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药现代(600420)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药现代(600420)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药现代,600420,国药现代股票,国药现代股票老虎,国药现代股票老虎国际,国药现代行情,国药现代股票行情,国药现代股价,国药现代股市,国药现代股票价格,国药现代股票交易,国药现代股票购买,国药现代股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药现代(600420)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药现代(600420)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}